Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                News & Events

News & Events

                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials Home
          News & Events
          Regenerative Medicine 101 Webinar: Information for Patients, Caregivers & Advocates - 11/16/2021News & Events Webcast
    Event Title
              Regenerative Medicine 101 Webinar: Information for Patients, Caregivers & Advocates


                  November 16, 2021

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
           

November 16, 2021

 





The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) hosted a public webinar on Tuesday, November 16, 11:00 a.m.-12:00 p.m. ET.

The webinar brought together patients, caregivers, advocates, and other important stakeholders to discuss how the FDA is working to advance regenerative medicine and its role in ensuring regenerative medicine treatments, such as approved gene therapies, are safe and effective for patients. The webinar speakers included Wilson Bryan, MD, Director of OTAT, and Anne Rowzee, PhD, Associate Director of Policy for OTAT.

This webinar was the first in an educational webinar series called RegenMedEd: An FDA CBER OTAT Webinar Series on Regenerative Medicine.

Promotional graphic for regenerative medicine 101 webinar hosted by the U.S. Food and Drug Administration. Image includes blue DNA helix.
About the RegenMedEd Webinar Series

Regenerative medicine therapies, such as cell and gene therapies, hold promise for transforming medicine and creating options for patients living with difficult, rare, and often incurable diseases. Several approved regenerative medicine products are currently available, and research into regenerative medicine therapies in the United States continues rapidly, with many new therapies under investigation advancing into clinical studies. The FDA plays a vital role in facilitating the development of regenerative medicine therapies, as well as in ensuring approved products are safe and effective for patients.

To further engage patients, caregivers, and advocates on the topic of regenerative medicine, OTAT is excited to present an educational webinar series called RegenMedEd: An FDA CBER OTAT Webinar Series on Regenerative Medicine. The RegenMedEd webinar series aims to bring together patients, caregivers, patient advocates, and FDA staff to discuss foundational information about regenerative medicine therapies, such as gene therapy and cell therapy, and explore opportunities for stakeholders to engage with the FDA to help advance drug development.

Recording

Zoom Webinar Recording for Regenerative Medicine 101 Webinar





Event Materials

  Title
            File Type/SizeSlides for the Regenerative Medicine 101 Webinar: Information for Patients, Caregivers & Advocates
              pdf               (1,005.01 KB)Transcripts for the Regenerative Medicine 101 Webinar: Information for Patients, Caregivers & Advocates
              pdf               (170.94 KB)

                                                                                  Content current as of:
      06/28/2022More Meetings,
      Conferences, and
      Workshops
        
        News & Events

          
                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop